Wang Xiaoguang, Wang Congqing
Department of Orthopedics, Affiliated Hospital of Bengbu Medical College, Bengbu Anhui, 233004, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005 Jun;19(6):435-8.
To study efficiency of vascularized bone graft combining with reconstituted bone xenograft (RBX) in repairing bone defect and the expression of the vascular endothelial growth factor (VEGF) in serum.
From January 1998 to December 2002, 27 cases of bones defects were treated and randomly divided into 3 groups according to different repair materials: group A (the vascularized bone graft- RBX group, n=9), group B (the vascularized bone graft group, n=10) and group C(the RBX group, n=8). The bone defect repair, the bone healing time and the bone graft resorption were observed by radiograph after 3 months, 6 months and 12 months of operation, and the expression of VEGF in serum was assayed with lumino-enzyme immunoassay before operation and after operative 2 weeks, 4 weeks, 6 weeks and 8 weeks respectively.
The X-ray films showed that the bone healing was achieved in 8 cases of group A, in 6 cases of group B and in 3 cases of group C after 3 months; in 1 case of group A, respectively in 3 cases of both group B and group C after 6 months. The bone graft resorption was observed in 1 case of group B and in 2 cases of group C after 12 months. The serum VEGF values after operative 2 weeks and 4 weeks were higher than those before operation in all of 3 groups (P<0. 05), and the VEGF values of groups A and B were higher than that group C(P<0. 05) after 4 weeks. There were no significant differences (P>0. 05) in serum VEGF level between postoperative 6, 8 weeks and pre-operation in 3 groups.
The expression of serum VEGF obviously increase in the early period of bone transplanting, it is value of clinical evaluation of reparative efficiency of bone defect.
研究带血管蒂骨移植联合重组异种骨(RBX)修复骨缺损的效果及血清中血管内皮生长因子(VEGF)的表达。
1998年1月至2002年12月,治疗27例骨缺损患者,根据不同修复材料随机分为3组:A组(带血管蒂骨移植-RBX组,n=9)、B组(带血管蒂骨移植组,n=10)和C组(RBX组,n=8)。分别于术后3个月、6个月和12个月通过X线片观察骨缺损修复情况、骨愈合时间及骨移植吸收情况,并分别于术前及术后2周、4周、6周和8周采用发光酶免疫分析法检测血清中VEGF的表达。
X线片显示,术后3个月A组8例、B组6例、C组3例实现骨愈合;术后6个月A组1例、B组和C组均为3例实现骨愈合。术后12个月,B组1例、C组2例观察到骨移植吸收。术后2周和4周时,3组血清VEGF值均高于术前(P<0.05),术后4周时A组和B组VEGF值高于C组(P<0.05)。术后6周和8周时3组血清VEGF水平与术前比较差异无统计学意义(P>0.05)。
骨移植早期血清VEGF表达明显升高,对骨缺损修复效果的临床评估有价值。